Attention: Matt Gantz, CEO Pat Morris, General Counsel, Paragon BiosciencesConfidential • July 16th, 2021 • Castle Creek Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 16th, 2021 Company IndustryThis letter (the “Agreement”) will confirm our understanding that Paragon Health Capital, LLC (“PHC”) has been hired to serve as the financial advisor to Castle Creek Biosciences, Inc. and/or its affiliates, subsidiaries or related companies that exist today or which may be created by you (“CCB” or the “Company”). This Agreement supersedes all prior agreements with CCB including the letter dated November 2, 2020.
Attention: Matt Gantz, CEO Pat Morris, General Counsel, Paragon BiosciencesConfidential • June 24th, 2021 • Castle Creek Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledJune 24th, 2021 Company IndustryThis letter (the “Agreement”) will confirm our understanding that Paragon Health Capital, LLC (“PHC”) has been hired to serve as the financial advisor to Castle Creek Biosciences, Inc. and/or its affiliates, subsidiaries or related companies that exist today or which may be created by you (“CCB” or the “Company”). This Agreement supersedes all prior agreements with CCB including the letter dated November 2, 2020.